Leap Therapeutics Ownership | Who Owns Leap Therapeutics?


OverviewForecastFinancialsChart

Leap Therapeutics Ownership Summary


Leap Therapeutics is owned by 33.00% institutional investors, and 67.00% retail investors. Prosperity wealth management is the largest institutional shareholder, holding 0% of LPTX shares. Simplify Health Care ETF is the top mutual fund, with 2.31% of its assets in Leap Therapeutics shares.

LPTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLeap Therapeutics33.00%-67.00%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Prosperity wealth management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Prosperity wealth management---

Top Buyers

HolderShares% AssetsChange
Prosperity wealth management---22.00K

Top Sellers

HolderShares% AssetsChange
Prosperity wealth management---22.00K

Sold Out

HolderChange
Prosperity wealth management-22.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202359-1.67%42,678,83830.93%323.98%24-1515.38%
Dec 31, 202260-13.04%32,596,715-11.84%282.70%24-7.69%13-7.14%
Sep 30, 202269-4.17%36,973,754-1.64%322.96%26-3.70%14-22.22%
Jun 30, 202272-16.28%37,590,637-12.87%332.29%27-35.71%1812.50%
Mar 31, 2022863.61%43,141,4000.60%382.65%42-22.22%16128.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Simplify Health Care ETF950.97K2.31%-24.64K
Vanguard Total Stock Mkt Idx Inv754.74K1.83%-
Vanguard US Total Market Shares ETF754.74K1.83%-
Vanguard Institutional Extnd Mkt Idx Tr394.33K0.96%-
BIT Biotech Opportunities S192.30K0.47%-
Fidelity Extended Market Index166.44K0.40%-1.06K
BlackRock Extended Equity Market K82.86K0.22%-35.00
Extended Equity Market Fund K81.98K0.20%251.00
BIT Global Leaders I - I81.00K0.20%-
iShares Micro-Cap ETF68.50K0.17%-

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q3--
2023 Q2--

LPTX Ownership FAQ


Who Owns Leap Therapeutics?

Leap Therapeutics shareholders are primarily institutional investors at 33.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Leap Therapeutics's industry, Biotech Stocks , is 68.48%, which Leap Therapeutics falls below.

Does Blackrock own Leap Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Leap Therapeutics.

Who is Leap Therapeutics’s biggest shareholder by percentage of total assets invested?

Prosperity wealth management is Leap Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Leap Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Leap Therapeutics shares?

Simplify Health Care ETF is the top mutual fund holder of Leap Therapeutics shares, with 2.31% of its total shares outstanding invested in 950.97K Leap Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools